Who owns SONNET BIOTHERAPEUTC HLDNG I?

Tip: Access positions for across all investors

Analyze quarterly positions in Sonnet Biotherapeutc Hldng I with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Sonnet Biotherapeutc Hldng I stock

Who bought or sold SONNET BIOTHERAPEUTC HLDNG I this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Ikarian Capital 150k $687k 100% Sep 2025
 View chart
Vanguard Group 96k $441k 100% Sep 2025
 View chart
Hrt Financial 74k $340k 100% Sep 2025
 View chart
Geode Capital Management 62k $283k 148% Sep 2025
 View chart
Boothbay Fund Management 56k $258k 100% Sep 2025
 View chart
Goldman Sachs Group 55k $253k 100% Sep 2025
 View chart
Citadel Advisors 46k $211k 100% Sep 2025
 View chart
Virtu Financial 26k $120k 100% Sep 2025
 View chart
State Street Corporation 23k $103k 100% Sep 2025
 View chart
BlackRock 22k $101k 33654% Sep 2025
 View chart
Northern Trust 18k $82k 100% Sep 2025
 View chart
Two Sigma Investments 15k $69k 100% Sep 2025
 View chart
Investment House 11k $49k 100% Sep 2025
 View chart
Jane Street 11k $48k 100% Sep 2025
 View chart
Jpmorgan Chase & Co 7.5k $35k 100% Sep 2025
 View chart
Larson Financial Group 4.3k $20k 100% Sep 2025
 View chart
Tower Research Capital 1.1k $4.8k -28% Sep 2025
 View chart
White Bay PT 1.0k $4.6k 100% Sep 2025
 View chart
Advisory Services Network 636.00 $2.9k 100% Sep 2025
 View chart
UBS Group 277.00 $1.3k -96% Sep 2025
 View chart
Golden State Wealth Management 202.00 $924.998400 100% Sep 2025
 View chart
Advisor Group Holdings 175.00 $567.997500 100% Sep 2025
 View chart
Carolina Wealth Advisors 32.00 $147.001600 0% Sep 2025
 View chart

Who sold out of Sonnet Biotherapeutc Hldng I?

Fund or Company Name Date Sold Shares Held Valued At
MMCAP International Inc. SPC Jun 2025 134k $166k
XTX Topco Jun 2025 14k $17k